News for 'COV'

NTAGI mulls 'additional' Covid jab for immunocompromised

NTAGI mulls 'additional' Covid jab for immunocompromised

Rediff.com5 Dec 2021

According to officials, an additional dose of vaccine is different from a booster dose.

Recovered people showing faster response to Covishield: Study

Recovered people showing faster response to Covishield: Study

Rediff.com3 Mar 2021

Those who have recovered from COVID-19 respond faster to the Covishield vaccine and reach high antibody levels, says a study, leading to hopes that they may not need a second dose and therefore help widen India's corona immunisation cover.

With Axar yet to recover, Delhi Capitals induct Mulani

With Axar yet to recover, Delhi Capitals induct Mulani

Rediff.com15 Apr 2021

Delhi Capitals have brought in Shams Mulani as a short-term COVID-19 replacement for Axar Patel for their IPL-2021 campaign.

Omicron: States told to step up testing; curbs extended till Dec 31

Omicron: States told to step up testing; curbs extended till Dec 31

Rediff.com30 Nov 2021

Union health secretary Rajesh Bhushan held a review meeting with states and Union Territories on Tuesday and advised them to ramp up testing for early identification and management of cases.

Mask Up, Covid Is Not Over Yet

Mask Up, Covid Is Not Over Yet

Rediff.com22 Dec 2022

'If there are any symptoms/variants of concern, states can prepare accordingly.'

Scientists break 'camouflage' of novel coronavirus

Scientists break 'camouflage' of novel coronavirus

Rediff.com26 Jul 2020

The researchers from the the University of Texas Health Science Center at San Antonio (UT Health San Antonio) in the United States said by enabling this modification, nsp10 protects the virus from host cell immune response.

Covid likely came from lab leak in China: Report

Covid likely came from lab leak in China: Report

Rediff.com27 Feb 2023

The new report highlights how different parts of the intelligence community have arrived at disparate judgments about the pandemic's origin.

ICMR revises advisory on use of hydroxychloroquine

ICMR revises advisory on use of hydroxychloroquine

Rediff.com23 May 2020

Three new categories -- all asymptomatic healthcare workers working in non-COVID hospitals/areas of COVID hospitals/blocks, asymptomatic frontline workers such as surveillance workers deployed in containment zones and paramilitary/police personnel involved in COVID-19 related activities -- have now been included.

Delta Plus variant: Govt alerts 8 states, UTs

Delta Plus variant: Govt alerts 8 states, UTs

Rediff.com25 Jun 2021

The Union health ministry on Friday urged eight states and Union Territories to take up immediate containment measures including preventing crowds, conducting widespread testing as well as increasing vaccine coverage on a priority basis in districts where the Delta Plus variant of coronavirus has been detected.

Experts downplay apprehensions centred around Covid XE

Experts downplay apprehensions centred around Covid XE

Rediff.com7 Apr 2022

Experts said the strain has not propelled a surge in cases like Omicron, but advised strict adherence to COVID-19-appropriate behaviour.

Omicron risk remains 'very high', says WHO

Omicron risk remains 'very high', says WHO

Rediff.com29 Dec 2021

The weekly epidemiological update by WHO revealed the week of December 20-26 saw the global number of new COVID-19 cases increase by 11 per cent as compared to the previous week.

Maha to withdraw all Covid curbs from April 2, masks not compulsory

Maha to withdraw all Covid curbs from April 2, masks not compulsory

Rediff.com31 Mar 2022

The decision was taken at a cabinet meeting chaired by Chief Minister Uddhav Thackeray, Health Minister Rajesh Tope told reporters.

Very low risk to newborns from Covid +ve moms: Study

Very low risk to newborns from Covid +ve moms: Study

Rediff.com13 Oct 2020

To reduce the risk of transmitting the SARS-CoV-2 virus to newborns after delivery, the researchers said the hospital staff practised social distancing, wore masks, and placed COVID-positive moms in private rooms.

Covid infection is not severe in kids, send them to school: Dr Gagandeep Kang

Covid infection is not severe in kids, send them to school: Dr Gagandeep Kang

Rediff.com31 Dec 2021

"In children, fortunately, infections with SARS-CoV-2 are generally not severe. There is a risk of long COVID, there is a risk of a very, very rare condition called MISC (Multisystem Inflammatory Syndrome) but by and large healthy children have nothing," said Dr Gagandeep Kang, leading Indian virologist.

Covaxin's 50 pc efficacy adequate for Covid, say experts

Covaxin's 50 pc efficacy adequate for Covid, say experts

Rediff.com26 Nov 2021

The decline in the effectiveness of Covaxin, India's indigenous COVID-19 vaccine, from 77.8 per cent to 50 per cent during a Delta-driven case surge in April and May this year is neither bad nor surprising, say scientists.

Study says coronavirus infects heart cells of patients

Study says coronavirus infects heart cells of patients

Rediff.com1 Jul 2020

"We not only uncovered that these stem cell-derived heart cells are susceptible to infection by novel coronavirus, but that the virus can also quickly divide within the heart muscle cells," said study co-author Arun Sharma from the Cedars-Sinai Board of Governors Regenerative Medicine Institute in the United States. "Even more significant, the infected heart cells showed changes in their ability to beat after 72 hours of infection," Sharma said.

Covishield booster works against Omicron

Covishield booster works against Omicron

Rediff.com24 Dec 2021

If the vaccine is recommended for use as a booster against Omicron, it may significantly boost the demand for Covishield in India.

Covaxin shows 78% efficacy in phase-3 interim analysis

Covaxin shows 78% efficacy in phase-3 interim analysis

Rediff.com21 Apr 2021

Safety and Efficacy results from the final analysis will be available in June, and the final report will be submitted to a peer-reviewed publication.

Researchers develop new N95 mask that can curb Covid spread, kill virus

Researchers develop new N95 mask that can curb Covid spread, kill virus

Rediff.com4 Jul 2022

The mask can potentially be worn longer, causing less plastic waste as it does not need to be replaced as frequently, the researchers said.

New Covid strain: Total 25 people in India test positive

New Covid strain: Total 25 people in India test positive

Rediff.com31 Dec 2020

These 25 people include the 20 who were found positive with the mutated strain on Tuesday and Wednesday.

Covid 3rd wave unlikely to be as severe as second: Study

Covid 3rd wave unlikely to be as severe as second: Study

Rediff.com25 Jun 2021

A third wave of COVID-19 -- if it occurs -- is unlikely to be as severe as the second wave given the extent of spread of coronavirus infections that has already taken place in the country, according to a study.

WHO criticises China for withholding Covid origin data

WHO criticises China for withholding Covid origin data

Rediff.com18 Mar 2023

"We continue to call on China to be transparent in sharing data and to conduct the necessary investigations and share the results. Understanding how the pandemic began remains both a moral and scientific imperative," Ghebreyesus said.

Oxford, AstraZeneca COVID-19 vaccine trials resume in UK

Oxford, AstraZeneca COVID-19 vaccine trials resume in UK

Rediff.com12 Sep 2020

AstraZeneca and the University of Oxford, as the trial sponsor, said that they cannot disclose further medical information but confirmed that independent investigations concluded that the trials were safe to restart.

India had 64 lakh COVID-19 infections by May: National serosurvey

India had 64 lakh COVID-19 infections by May: National serosurvey

Rediff.com11 Sep 2020

Seropositivity was the highest in the age group of 18-45 years (43.3 per cent), followed by those between 46-60 years (39.5 per cent) and it was the lowest among those aged above 60 (17.2 per cent).

Cold, Flu Or COVID-19? Know The Difference

Cold, Flu Or COVID-19? Know The Difference

Rediff.com24 Jan 2022

Dr Karthiyayini Mahadevan tells you how to differentiate between a cold, flu and COVID-19 and take appropriate action.

US allows 'game-changer' saliva-based Covid test

US allows 'game-changer' saliva-based Covid test

Rediff.com16 Aug 2020

The new test it will enable rapid testing amongst more people easily.

'Strong evidence' COVID-19 predominantly spreads through air: Study

'Strong evidence' COVID-19 predominantly spreads through air: Study

Rediff.com16 Apr 2021

The researchers noted that transmission rates of SARS-CoV-2 are much higher indoors than outdoors, and transmission is greatly reduced by indoor ventilation.

More COVID cases at Tokyo Olympic Village

More COVID cases at Tokyo Olympic Village

Rediff.com22 Jul 2021

Two athletes residing in the Olympic village tested positive for COVID-19.

Repeat Covid infections increase organ failure, death risk: Study

Repeat Covid infections increase organ failure, death risk: Study

Rediff.com11 Nov 2022

The study also indicated that the risk seems to increase with each infection.

Unwarranted to think COVID-19 will vanish in summer: Virologist

Unwarranted to think COVID-19 will vanish in summer: Virologist

Rediff.com11 May 2020

The arrival of summer in India may have raised hopes that hot and humid weather could slow the COVID-19 progression but virologist Naga Suresh Veerapu believes that outbreak and pandemic occurrences often do not follow seasonality.

Centre studies if coronavirus present in Ganga water

Centre studies if coronavirus present in Ganga water

Rediff.com8 Jun 2021

The Centre is conducting a study to assess the presence of SARS-CoV-2, or novel coronavirus, in the Ganga as corpses were found dumped in the river during the second Covid wave, and were fished out from districts in Uttar Pradesh and Bihar, officials said.

Covid vax don't give total protection: WHO scientist

Covid vax don't give total protection: WHO scientist

Rediff.com12 Aug 2021

"Even though the vaccine may not be able to provide absolute protection against different variants of virus, it can certainly reduce the risk of death and complications," a statement quoting WHO chief scientist Soumya Swaminathan said.

Self-use Covid-19 testing kits to be available at stores for Rs 250

Self-use Covid-19 testing kits to be available at stores for Rs 250

Rediff.com21 May 2021

Pune's Mylab Discovery Solutions' CoviSelf, which gives results in 15 minutes, gets ICMR nod

Covaxin output scaled up to 500 million jabs a year: Bharat Biotech

Covaxin output scaled up to 500 million jabs a year: Bharat Biotech

Rediff.com17 May 2021

This apart, to further increase capacities, Bharat Biotech has partnered with Indian Immunologicals (IIL) to manufacture the drug substance for Covaxin. The technology transfer process is underway and IIL has the 'capabilities and expertise' to manufacture the inactivated viral vaccines at commercial scale.

'COVID-19 can quietly enter your body, without causing pain'

'COVID-19 can quietly enter your body, without causing pain'

Rediff.com3 Dec 2020

'The COVID-19 virus has the power to quietly enter your body, without causing pain via symptoms, because it craftily manipulates your pain response.'

Covid: PM chairs high-level meet, stresses on oxygen availability

Covid: PM chairs high-level meet, stresses on oxygen availability

Rediff.com11 Sep 2021

Modi stressed on the need for constant genome sequencing to monitor emergence of mutants and also to ensure increased oxygen availability, the Prime Minister's Office (PMO) said in a statement.

Vaccination 3 months after recovery from Covid: Govt

Vaccination 3 months after recovery from Covid: Govt

Rediff.com19 May 2021

These decisions were taken by the ministry based on the fresh recommendations by The National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) and have also been communicated to the states and union territories, an official statement said.

COVID-19: 'We will be dealing with it for 2 years at least'

COVID-19: 'We will be dealing with it for 2 years at least'

Rediff.com29 Oct 2020

'The most intriguing thing (about COVID-19) is the range of the illness -- from asymptomatic or less symptoms to death and quite severe manifestations.' 'The vaccine will be at least another year away from having any effect.'

Zydus's India-made Covid vaccine gets emergency use approval

Zydus's India-made Covid vaccine gets emergency use approval

Rediff.com20 Aug 2021

This is the world's first DNA-based vaccine against the coronavirus, and this three-dose vaccine when injected produces the spike protein of the SARS-CoV-2 virus and elicits an immune response, which plays a vital role in protection from the disease as well as viral clearance

Kids unlikely to get disproportionately hit by 3rd wave: Study

Kids unlikely to get disproportionately hit by 3rd wave: Study

Rediff.com17 Jun 2021

The SARS-CoV-2 sero-positivity rate among children is high and comparable to the adult population and hence, it is unlikely that any future third wave of the prevailing COVID-19 variant would disproportionately affect children aged two years and above, according to the interim findings of an ongoing study conducted in the country.